|
Bruce Alberts
Dan
Burkhardt
France A. Córdova
William
H. Danforth
Brady J.
Deaton
Hugh Grant
Richard
Herman
David W.
Kemper
Alex F.
McCalla
John
F. McDonnell
Philip
Needleman
Peter H.
Raven
Alfonso
Romo Garza
P. Roy
Vagelos
Robert L.
Virgil
Mark S.
Wrighton
Usha
Barwale Zehr
|
Board of Trustees
P.
Roy Vagelos
Retired Chairman of the Board
and Chief Executive Officer
Merck & Co., Inc.
Dr. Vagelos served as Chief
Executive Officer of Merck &
Co., Inc. for nine years, from
July 1985 to June 1994. He was
first elected to the Board of
Directors in 1984 and served as
its Chairman from April 1986 to
November 1994. He was previously
Executive Vice President of the
worldwide health products
company and, before that,
President of its Research
Division, which he joined in
1975.
Earlier, he served as Chairman
of the Department of Biological
Chemistry of the School of
Medicine at Washington
University in St. Louis and as
Founding Director of the
University's Division of Biology
and Biomedical Sciences. He had
previously held senior positions
in cellular physiology and
biochemistry at the National
Heart Institute, after
internship and residency at
Massachusetts General Hospital.
The author of more than 100
scientific papers, Dr. Vagelos
received the Enzyme Chemistry
Award of the American Chemical
Society in 1967. He is a member
of the National Academy of
Sciences, the American Academy
of Arts and Sciences and the
American Philosophical Society.
He has received honorary Doctor
of Science degrees from
Washington University, Brown
University, the University of
Medicine and Dentistry of New
Jersey, New York University,
Columbia University, the New
Jersey Institute of Technology,
Pamukkale University in Turkey,
Mount Sinai Medical Center and
the University of British
Columbia; an honorary Doctor of
Laws degrees from Princeton
University, the University of
Pennsylvania and Harvard
University; and an honorary
Doctor of Humane Letters from
Rutgers University. He received
the Thomas Alva Edison Award
from Thomas Kean, the Lawrence
A. Wien Prize from Columbia
University, the C. Walter
Nichols Award from New York
University's Stern School of
Business, the National Academy
of Science Award for Chemistry
in Service to Society, the Othmer Gold Medal from the
Chemical Heritage Foundation,
and the 1999 Bower Award in
Business Leadership from the
Franklin Institute. His Majesty
the King in Bangkok, Thailand
awarded the Prince Mahidol Award
to Dr. Vagelos in January 1998.
Dr. Vagelos was Chairman of the
Board of Trustees of the
University of Pennsylvania from
October 1994-June 1999, having
served as a trustee since 1988.
He also served as Co-Chairman of
the New Jersey Performing Arts
Center from 1989-1999 and was
President and CEO of the
American School of Classical
Studies at Athens from
1999-2001.
Dr. Vagelos is a Director of the
Donald Danforth Plant Sciences
Center and a Trustee of The
Danforth Foundation.
He is also Chairman of the Board
of Regeneron Pharmaceuticals,
Inc. and Theravance, Inc.
Dr. Vagelos was Chairman of the
Review, Planning and
Implementation Steering
Committee of New Jersey and the
Commission on Jobs Growth and
Economic Development.
Dr. Vagelos is Chairman of the
Board of Visitors of Columbia
University Medical Center and
also Chairman of a $1 billion
capital campaign.
|